158 related articles for article (PubMed ID: 32717612)
41. Design, synthesis and biological evaluation of 1,3-dihydroxyxanthone derivatives: Effective agents against acetylcholinesterase.
Menéndez CA; Biscussi B; Accordino S; Paula Murray A; Gerbino DC; Appignanesi GA
Bioorg Chem; 2017 Dec; 75():201-209. PubMed ID: 28963904
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease.
Fernandes TB; Cunha MR; Sakata RP; Candido TM; Baby AR; Tavares MT; Barbosa EG; Almeida WP; Parise-Filho R
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 28940630
[TBL] [Abstract][Full Text] [Related]
45. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
47. Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.
Mohammadi-Khanaposhtani M; Mahdavi M; Saeedi M; Sabourian R; Safavi M; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Chem Biol Drug Des; 2015 Dec; 86(6):1425-32. PubMed ID: 26077890
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
49. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of genistein-O-alkylamine derivatives as potential multifunctional anti-Alzheimer agents.
Hong C; Guo HY; Chen S; Lv JW; Zhang X; Yang YC; Huang K; Zhang YJ; Tian ZY; Luo W; Chen YP
Chem Biol Drug Des; 2019 Feb; 93(2):188-200. PubMed ID: 30299583
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis and biological assessment of acridine derivatives containing 1,3,4-thiadiazole moiety as novel selective acetylcholinesterase inhibitors.
Lotfi S; Rahmani T; Hatami M; Pouramiri B; Kermani ET; Rezvannejad E; Mortazavi M; Fathi Hafshejani S; Askari N; Pourjamali N; Zahedifar M
Bioorg Chem; 2020 Dec; 105():104457. PubMed ID: 33339082
[TBL] [Abstract][Full Text] [Related]
52. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors.
Sukumaran SD; Chee CF; Viswanathan G; Buckle MJ; Othman R; Abd Rahman N; Chung LY
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455222
[TBL] [Abstract][Full Text] [Related]
55. Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease.
Hu J; Huang YD; Pan T; Zhang T; Su T; Li X; Luo HB; Huang L
ACS Chem Neurosci; 2019 Jan; 10(1):537-551. PubMed ID: 30252439
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
Li JC; Zhang J; Rodrigues MC; Ding DJ; Longo JP; Azevedo RB; Muehlmann LA; Jiang CS
Bioorg Med Chem Lett; 2016 Aug; 26(16):3881-5. PubMed ID: 27426301
[TBL] [Abstract][Full Text] [Related]
58. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase.
Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V
Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057
[TBL] [Abstract][Full Text] [Related]
59. Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.
Basiri A; Xiao M; McCarthy A; Dutta D; Byrareddy SN; Conda-Sheridan M
Bioorg Med Chem Lett; 2017 Jan; 27(2):228-231. PubMed ID: 27914796
[TBL] [Abstract][Full Text] [Related]
60. Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease.
Mao F; Wang H; Ni W; Zheng X; Wang M; Bao K; Ling D; Li X; Xu Y; Zhang H; Li J
ACS Chem Neurosci; 2018 Feb; 9(2):328-345. PubMed ID: 29068218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]